2027 Printed Publications Early Bird Sale on Now through October 2, 2026!



User Information

Create New Account

Lost Password

Username:
Password:

Quick Links


LCDs and LCAs by
Contractor

PLA Codes

Laboratory Fee Schedule

2026
2025
QW Tests

Physician Fee Schedule

2026 non-QP

Physician Fee Schedule-QP

2026-QP

OPPS Fee Schedule

2026-July
2026-April

ASC Fee Schedule

2026-July
2026-April

APC Codes

2026-July
2026-April

DRG Codes

2026
2025

ASP Drug Pricing Files

2026-July
2026-April


CMS Transmittals



CodeMap® LCD-L38121

 

Printer Friendly Version

L38121
LCD for MolDX: Next-Generation Sequencing for Solid Tumors (L38121)

See related Articles:
A56518-Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Testing in Cancer
A57905-Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57906-Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors

Contractor Information

Contractor Name: Noridian Healthcare Solutions, LLC - Full list of policies of this Medicare Contractor

Contractor Number: 03302

Contractor Type: MAC B

LCD Information

LCD ID Number: L38121 Status: R- Retired

LCD Title: MolDX: Next-Generation Sequencing for Solid Tumors

Geographic Jurisdiction: North Dakota Other Jurisdictions

Original Determination Effective Date: 05/17/2020

Original Determination Ending Date: 02/05/2026

Revision Effective Date: 06/08/2023

Revision End Date: 02/05/2026

CMS National Coverage Policy:

Title XVIII of the Social Security Act (SSA), §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that “are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.”

42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions

CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes

CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 2, §90.2 Next-Generation Sequencing (NGS) for Patients with Advanced Cancer


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*


All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

09/16/2026 07:25:22 18.97.14.81

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.